Skip to main content


It was a slow month for next generation Covid vaccine results reporting, but a big month for clinical trial news:

- A new clinical trial for intranasal and inhaled versions of a vax is on the starting blocks in the US;

- Another intranasal vax trial has expanded to another 2 cities in the US; and

- A trial for a "variant-proof" vax going into phase 2a trial in Germany.

Plus some preclinical reports & more in my latest monthly update @PLOS

absolutelymaybe.plos.org/2026/…

#Vaccines #Covid #Covid19

⇧